Acute Lymphoblastic Leukaemia- A Review
Keywords:
MedicineReferences
and childhood: in the tradition of C.H. Smith. 7th
ed. St Louis: Mosby Publishing; 1995. p. 660-
712.
2. Nathan DG, Orkin, SH. Hematology of infancy
and childhood. 5th ed. Philadelphia: WB Saunders;
1998. p. 1256-62.
3. Smith M, Arthur D, Camitta B,Carroll AJ, Crist W,
Gaynon P. Uniform approach to risk classification
and treatment assignment for children with acute
lymphoblastic leukemia. Journal of Clinical
Oncology 1996; 14 (1): 18-24.
4. Crist W, Shuster J, Rook T, Borowitz M, Behm F,
Bowman P. Current results of studies of
immunophenotype-, age-, and leukocyte-based
treatment for children with acute lymphoblastic
leukemia. Leukemia 1992; (6 Suppl 2): 162-5.
5. Chessels JM, Bailey C, Richards SM. Intensification
of treatment and survival in all children with
lymphoblastic leukaemia: results of the Medical
Research Council Trial UKALL X. Lancet 1995;
345: 143-8.
6. Sorensen K, Levitt G, Bull C, Chestells J, Sullivan
I. Anthracycline dose in childhood acute
lymphoblastic leukemia: Issues of early survival
versus late cardiotoxicity. Journal of Clinical
Oncology 1997; 15 (1): 61-8.
7. Bleyer WA. Acute lymphoblastic leukemia in
children, advances and prospectus. Cancer 1990;
65: 689-95.
8. Pinkel D. Therapy of acute lymphoblastic leukemia
in children. Leukemia 1992; (6 Suppl 2): 127-32.
9. Gale RP, Butturini A. Controversies in the
treatment of acute lymphoblastic leukemia.
Leukemia 1992; (6 Suppl 2): 144-7.
10. Barnett AJ. Allogenic bone marrow transplant for
acute lymphoblastic leukemia. Leukemia 1992 (6
Suppl 2): 139-44.
Downloads
Published
How to Cite
Issue
Section
License
Authors retain copyright and grant the journal the right of first publication with the work simultaneously licensed under a Creative Commons Attribution (CC-BY) 4.0 License that allows others to share the work with an acknowledgement of the work’s authorship and initial publication in this journal.
Provided they are the owners of the copyright to their work, authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work (e.g., post it to an institutional repository, in a journal or publish it in a book), with an acknowledgement of its initial publication in this journal.